rss
J Neurol Neurosurg Psychiatry 2006;77:1150-1156 doi:10.1136/jnnp.2005.076083
  • Paper

Interaction of homocysteine and conventional predisposing factors on risk of ischaemic stroke in young people: consistency in phenotype-disease analysis and genotype-disease analysis

  1. A Pezzini1,
  2. M Grassi2,
  3. E Del Zotto1,
  4. D Assanelli3,
  5. S Archetti4,
  6. R Negrini5,
  7. L Caimi6,
  8. A Padovani1
  1. 1Clinica Neurologica, Università degli Studi di Brescia, Brescia, Italy
  2. 2Dipartimento di Scienze Sanitarie Applicate, Sezione di Statistica Medica ed Epidemiologia, Università degli Studi di Pavia, Pavia, Italy
  3. 3Dipartimento di Scienze Mediche e Chirurgiche, Università degli Studi di Brescia
  4. 4III Laboratorio di Analisi, Biotecnologie, Università degli Studi di Brescia
  5. 5Laboratorio di Microbiologia, Università degli Studi di Brescia
  6. 6Dipartimento di Biochimica, Università degli Studi di Brescia
  1. Correspondence to:
 Alessandro Pezzini
 Clinica Neurologica, Università degli Studi di Brescia, Ple Spedali Civili, 1, 25100 Brescia, Italy; ale_pezzini{at}hotmail.com
  • Received 16 July 2005
  • Accepted 7 April 2006
  • Revised 8 March 2006
  • Published Online First 19 April 2006

Abstract

Background and objectives: Whether the association between mild hyperhomocysteinaemia and ischaemic stroke is the consequence of a predisposing genetic background or is due to the confounding influence of established predisposing factors remains to be determined.

Methods: Plasma total homocysteine (tHcy) concentration and the distribution of the C677T genotypes of the methylenetetrahydrofolate reductase gene (MTHFR) were compared in 174 consecutive patients with stroke aged <45 years and 155 age and sex-matched controls. The effect of conventional risk factors on the relationship between phenotype-disease and genotype-disease was analysed by two-way and three-way interaction analysis and by the classification and regression trees (CART) model.

Results: tHcy concentrations were markedly higher in patients with ischaemic stroke (median 11.9 μmol/l, range 2.0–94.0) than in controls (median 9.8 μmol/l, range 4.7–49.6). An increased risk was also associated with the TT677 genotype (odds ratio (OR) 1.98; 95% confidence interval (CI) 1.04 to 3.78) and with the T allele (1.40; 95% 1.03 to 1.92) of the MTHFR gene. A differential effect of Hcy levels on risk of stroke was observed according to the distribution of environmental–behavioural risk factors, with a stronger influence in the subcategory of people with hypertension and smokers (OR 24.8; 95% CI 3.15 to 196). A comparable environmental-dependent TT677 MTHFR genotype–stroke association was observed in the genotype-disease analysis.

Conclusions: A consistency of phenotype-disease analysis and genotype-disease analysis is indicated by analysing specific subcategories of patients, defined by the distribution of established risk factors. The assumption that the Hcy–stroke relationship is unlikely due to a reverse-causality bias is indirectly supported by our data.

Footnotes

  • See Editorial Commentary, p 1103

  • Published Online First 19 April 2006

  • Competing interests: None declared.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs